Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

A Comparison of the Beta-Adrenergic Receptor of the Turkey Erythrocyte with Mammalian Beta1 and Beta2 Receptors

KENNETH P. MINNEMAN, GREGORY A. WEILAND and PERRY B. MOLINOFF
Molecular Pharmacology January 1980, 17 (1) 1-7;
KENNETH P. MINNEMAN
Department of Pharmacology, University of Colorado Medical Center, 4200 East Ninth Avenue, Denver, Colorado 80262
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GREGORY A. WEILAND
Department of Pharmacology, University of Colorado Medical Center, 4200 East Ninth Avenue, Denver, Colorado 80262
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PERRY B. MOLINOFF
Department of Pharmacology, University of Colorado Medical Center, 4200 East Ninth Avenue, Denver, Colorado 80262
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The kinetic and pharmacological properties of β-adrenergic receptors in turkey erythrocyte membranes have been characterized by measuring adenylate cyclase activity and specific binding of 125I-iodohythoxybenzylpindolol (IHYP). Receptor properties have been compared to those of β1, and β2 receptors in a number of mammalian tissues. The affinity (KD) of IHYP for the turkey erythrocyte β-adrenergic receptor (42 pM) was similar to the KD for IHYP binding to either β1 or β2 receptors. However, the rates of both association (k1) and dissociation (k-1) of IHYP were 6-10 times faster when measured with β-adrenergic receptors on turkey erythrocytes than were observed for either β1 or β2 receptors in various mammalian tissues. Thermodynamic analysis of the k1 for IHYP binding in the turkey erythrocyte and rat heart showed similar enthalpies of activation (ΔH‡), suggesting that the different k1 values arise mainly from different entropies of activation (ΔH‡) in the two tissues. The order of potency of drugs for activation or inhibition of adenylate cyclase activity correlated well with that for inhibition of IHYP binding in the turkey erythrocyte. However, both the Ki and Kact values for adenylate cyclase were generally two to three times higher than the corresponding KD value determined from studies of the inhibition of IHYP binding. The pharmacological effects of a variety of drugs with similar or different affinities for β1- and β2-adrenergic receptors were determined on membranes prepared from turkey erythrocytes. The KD values for nonselective drugs in the turkey erythrocyte were identical to their KD values for β1, and β2 receptors, suggesting that this receptor should be classified as a β-adrenergic receptor. However, the KD values in the turkey erythrocyte for selective drugs did not correlate with the KD values for these drugs at either β1 or β2 receptors. Furthermore, the efficacies of partial agonists at turkey erythrocyte β-adrenergic receptors did not correlate with their efficacies for either β1 or β2 receptors. The results demonstrate that the β-adrenergic receptor in the turkey erythrocyte has kinetic and pharmacological properties distinct from either mammalian β1 or β2 receptors.

ACKNOWLEDGMENTS We thank Beth Goens for excellent technical assistance and Candace Plesha for preparing the manuscript.

  • Copyright © 1980 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 17, Issue 1
1 Jan 1980
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Comparison of the Beta-Adrenergic Receptor of the Turkey Erythrocyte with Mammalian Beta1 and Beta2 Receptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

A Comparison of the Beta-Adrenergic Receptor of the Turkey Erythrocyte with Mammalian Beta1 and Beta2 Receptors

KENNETH P. MINNEMAN, GREGORY A. WEILAND and PERRY B. MOLINOFF
Molecular Pharmacology January 1, 1980, 17 (1) 1-7;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

A Comparison of the Beta-Adrenergic Receptor of the Turkey Erythrocyte with Mammalian Beta1 and Beta2 Receptors

KENNETH P. MINNEMAN, GREGORY A. WEILAND and PERRY B. MOLINOFF
Molecular Pharmacology January 1, 1980, 17 (1) 1-7;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • GABAAR Molecular Identity in Oligodendrocytes
  • Editing TOP2α Intron-19 5′ SS Circumvents Drug Resistance
  • SerpinA3N and drug induced liver injury
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics